Brief: Rapport Therapeutics To Announce Topline Results For Rap-219 Phase 2A Trial In Focal Onset Seizures On Monday, September 8, 2025
Rapport Therapeutics Inc RAPP.O: RAPPORT THERAPEUTICS TO ANNOUNCE TOPLINE RESULTS FOR RAP-219 PHASE 2A TRIAL IN FOCAL ONSET SEIZURES ON MONDAY, SEPTEMBER 8, 2025 Source text: ID:nGNX2lTDg1 Further company coverage: RAPP.O